Yigal Nochomovitz
Stock Analyst at Citigroup
(3.54)
# 912
Out of 5,112 analysts
329
Total ratings
46.01%
Success rate
6.34%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals | Maintains: Buy | $21 → $60 | $30.81 | +94.74% | 3 | Dec 12, 2025 | |
| DRTS Alpha Tau Medical | Maintains: Buy | $8 → $7 | $5.01 | +39.72% | 1 | Dec 10, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $12 → $16 | $8.09 | +97.90% | 7 | Nov 17, 2025 | |
| CADL Candel Therapeutics | Maintains: Buy | $25 → $24 | $5.54 | +333.21% | 2 | Nov 14, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Neutral | $12 → $9 | $6.43 | +39.97% | 8 | Nov 13, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $87 → $77 | $54.84 | +40.41% | 22 | Nov 12, 2025 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $33 → $31 | $21.17 | +46.43% | 4 | Nov 11, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $7 → $6 | $1.35 | +344.44% | 11 | Nov 10, 2025 | |
| ONC BeOne Medicines AG | Maintains: Buy | $399 → $405 | $307.02 | +31.91% | 1 | Nov 10, 2025 | |
| SLDB Solid Biosciences | Maintains: Buy | $16 → $14 | $5.28 | +165.15% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $166 → $198 | $233.37 | -15.16% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $5.68 | +93.66% | 16 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $1.63 | +390.80% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $45 | $24.48 | +83.82% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $56 | $21.99 | +154.66% | 9 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $203 | $141.84 | +43.12% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $46 | $35.07 | +31.17% | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $26.60 | +24.06% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $17.04 | +134.74% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $97 | $96.80 | +0.21% | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $17.18 | +301.63% | 9 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $26.40 | -16.67% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.2 → $1.9 | $1.18 | +61.02% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $51 | $20.23 | +152.10% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $17.07 | +204.63% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $20.34 | -65.59% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.47 | +264.37% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9.5 | $11.28 | -15.78% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $41.77 | +31.67% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $17.06 | +93.43% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.12 | +6,372.49% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $2.96 | -32.43% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $33.26 | +74.38% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.57 | +791.72% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.34 | -10.45% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.10 | -4.76% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.01 | +59.68% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $6.48 | -84.57% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $17.23 | +103.13% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $32.84 | +304.99% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $4.15 | +285.54% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.05 | +852.38% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.76 | +581.82% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.62 | - | 14 | Sep 28, 2021 |
Olema Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $21 → $60
Current: $30.81
Upside: +94.74%
Alpha Tau Medical
Dec 10, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $5.01
Upside: +39.72%
ORIC Pharmaceuticals
Nov 17, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $8.09
Upside: +97.90%
Candel Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $5.54
Upside: +333.21%
Arcturus Therapeutics Holdings
Nov 13, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.43
Upside: +39.97%
CRISPR Therapeutics AG
Nov 12, 2025
Maintains: Buy
Price Target: $87 → $77
Current: $54.84
Upside: +40.41%
ArriVent BioPharma
Nov 11, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $21.17
Upside: +46.43%
Biomea Fusion
Nov 10, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $1.35
Upside: +344.44%
BeOne Medicines AG
Nov 10, 2025
Maintains: Buy
Price Target: $399 → $405
Current: $307.02
Upside: +31.91%
Solid Biosciences
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $5.28
Upside: +165.15%
Nov 4, 2025
Maintains: Neutral
Price Target: $166 → $198
Current: $233.37
Upside: -15.16%
Nov 3, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $5.68
Upside: +93.66%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $1.63
Upside: +390.80%
Oct 31, 2025
Maintains: Buy
Price Target: $52 → $45
Current: $24.48
Upside: +83.82%
Oct 29, 2025
Maintains: Buy
Price Target: $54 → $56
Current: $21.99
Upside: +154.66%
Oct 29, 2025
Maintains: Buy
Price Target: $175 → $203
Current: $141.84
Upside: +43.12%
Oct 28, 2025
Maintains: Buy
Price Target: $27 → $46
Current: $35.07
Upside: +31.17%
Oct 21, 2025
Initiates: Buy
Price Target: $33
Current: $26.60
Upside: +24.06%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $17.04
Upside: +134.74%
Sep 29, 2025
Downgrades: Neutral
Price Target: $101 → $97
Current: $96.80
Upside: +0.21%
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $17.18
Upside: +301.63%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $26.40
Upside: -16.67%
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.18
Upside: +61.02%
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $20.23
Upside: +152.10%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $17.07
Upside: +204.63%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $20.34
Upside: -65.59%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.47
Upside: +264.37%
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $11.28
Upside: -15.78%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $41.77
Upside: +31.67%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $17.06
Upside: +93.43%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.12
Upside: +6,372.49%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $2.96
Upside: -32.43%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $33.26
Upside: +74.38%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.57
Upside: +791.72%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.34
Upside: -10.45%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.10
Upside: -4.76%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.01
Upside: +59.68%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $6.48
Upside: -84.57%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $17.23
Upside: +103.13%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $32.84
Upside: +304.99%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $4.15
Upside: +285.54%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.05
Upside: +852.38%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.76
Upside: +581.82%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.62
Upside: -